Xiao-qin Liu

12 Middle Urumqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Model-informed precision pyrazinamide dosing: The establishment of a population pharmacokinetic model repository for clinical decision support.

Model-informed precision pyrazinamide dosing: The establishment of a population pharmacokinetic model repository for clinical decision support.

Journal: International journal of antimicrobial agents

Published: June 02, 2025

Once- Versus Twice-Daily Tacrolimus Therapy: Does Improved Adherence Lead to Better Efficacy?-A Pharmacokinetic Perspective.

Once- Versus Twice-Daily Tacrolimus Therapy: Does Improved Adherence Lead to Better Efficacy?-A Pharmacokinetic Perspective.

Journal: Journal of clinical pharmacology

Published: January 21, 2025

Assessment of Rivaroxaban Plasma Concentration Using Chromogenic Anti-Xa Assays and UHPLC-MS/MS in Chinese Patients With Atrial Fibrillation.

Assessment of Rivaroxaban Plasma Concentration Using Chromogenic Anti-Xa Assays and UHPLC-MS/MS in Chinese Patients With Atrial Fibrillation.

Journal: Basic & clinical pharmacology & toxicology

Published: July 30, 2024

Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia.

Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia.

Journal: Journal of pharmaceutical sciences

Published: June 18, 2024

Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing.

Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing.

Journal: Blood advances

Published: June 11, 2024

Insights into the population pharmacokinetics and pharmacodynamics of quetiapine: a systematic review.

Insights into the population pharmacokinetics and pharmacodynamics of quetiapine: a systematic review.

Journal: Expert review of clinical pharmacology

Published: December 18, 2023

Significant predictors for olanzapine pharmacokinetics: a systematic review of population pharmacokinetic studies.

Significant predictors for olanzapine pharmacokinetics: a systematic review of population pharmacokinetic studies.

Journal: Expert review of clinical pharmacology

Published: May 26, 2023

Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban.

Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban.

Journal: Pharmaceutics

Published: December 04, 2022

Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing.

Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing.

Journal: Neurology

Published: April 06, 2022

Real-World Prescription Patterns For Patients With Young-Onset Parkinson's Disease in China: A Trend Analysis From 2014 to 2019.

Real-World Prescription Patterns For Patients With Young-Onset Parkinson's Disease in China: A Trend Analysis From 2014 to 2019.

Journal: Frontiers in pharmacology

Published: January 19, 2022

How to handle a delayed or missed dose of edoxaban in patients with non-valvular atrial fibrillation? A model-informed remedial strategy.

How to handle a delayed or missed dose of edoxaban in patients with non-valvular atrial fibrillation? A model-informed remedial strategy.

Journal: British journal of clinical pharmacology

Published: October 31, 2021

Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation.

Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation.

Journal: Acta pharmacologica Sinica

Published: October 20, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026